Invention Grant
- Patent Title: Anti-αβTCR antibody
-
Application No.: US14241099Application Date: 2012-09-12
-
Publication No.: US10017573B2Publication Date: 2018-07-10
- Inventor: Daniel Snell , Andreas Menrad , Gina Lacorcia , Srinivas Shankara , Huawei Qiu , Clark Pan , Benjamin Kebble
- Applicant: Daniel Snell , Andreas Menrad , Gina Lacorcia , Srinivas Shankara , Huawei Qiu , Clark Pan , Benjamin Kebble
- Applicant Address: US MA Cambridge
- Assignee: GENZYME CORPORATION
- Current Assignee: GENZYME CORPORATION
- Current Assignee Address: US MA Cambridge
- Agency: Lathrop Gage LLP
- Agent James H. Velema, Esq.
- International Application: PCT/EP2012/003819 WO 20120912
- International Announcement: WO2013/037484 WO 20130321
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28
Abstract:
The present invention relates to humanized monoclonal antibodies comprising the CDRs of murine antibody BMA031, which bind to the apTCR.CD3 complex and possess improved biological properties.
Public/Granted literature
- US20150099861A1 ANTI ALPHABETATCR ANTIBODY Public/Granted day:2015-04-09
Information query
